4.70 USD
↗ 0.30 (6.82%)AT CLOSE (11:59 AM EDT)
Prelude Therapeutics Incorporated
PRLDNASDAQ • USD
4.76
↗ 0.06 (1.30%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
4.76
↗ 0.06 (1.30%)
Market: CLOSED
Open?$4.88
High?$4.88
Low?$4.44
Prev. Close?$4.40
Volume?865.2K
Avg. Volume?342.6K
VWAP?$4.67
Rel. Volume?2.53x
Bid / Ask
Bid?$3.95 × 100
Ask?$5.36 × 100
Spread?$1.41
Midpoint?$4.66
Valuation & Ratios
Market Cap?380.8M
Shares Out?63.0M
Float?17.1M
Float %?39.0%
P/E Ratio?N/A
P/B Ratio?5.55
EPS?-$1.23
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.99Adequate
Quick Ratio?1.99Adequate
Cash Ratio?0.67Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?5.55FAIR▾
P/S?31.37HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
EV/Sales?28.46HIGH▾
Returns & Efficiency
ROE?-145.0%WEAK▾
ROA?-70.4%WEAK▾
Cash Flow & Enterprise
FCF?$-56369000
Enterprise Value?$345.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
Employees
79
Market Cap
380.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-09-25
Address
175 INNOVATION BOULEVARD
WILMINGTON, DE 19805
Phone: (302) 467-1280
WILMINGTON, DE 19805
Phone: (302) 467-1280